drugset / Trial / NCT04524897

The Use of Triamcinolone Injection in Treatment of Refractory Benign Esophageal Stricture in Children

NCT04524897

Phase 4 Unknown 20 enrolled Assiut University
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy of Intra-lesional triamcinolone injection in the management of refractory benign esophageal Stricture in children.

Timeline

Start
2020-12-01
Primary completion
2021-10
Completion
2022-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Other / unclassified 40 mg/ml Other

Indications

No indication recorded.